Bowel cancer, also known as colorectal cancer, can affect any part of the colon or rectum; it may also be referred to as colon cancer or rectal cancer, depending on where the cancer is located.
Bowel cancer screening is for people who do not already have bowel cancer, symptoms of bowel cancer, or any reason to have a high risk of bowel cancer.
Patient-centred care is healthcare that is respectful of, and responsive to, the preferences, needs and values of patients and consumers.
Bowel Cancer Australia provides essential support services uniquely designed for bowel cancer patients via our confidential Helpline with specialist telehealth support, as well as a national Peer-to-Peer Support Network and Buddy Program.
Bowel Cancer Australia funds research that has the potential to improve survival and/or help build a path toward a cure and integrates published research into our awareness, advocacy, and support strategies.
Bowel Cancer Australia relies upon donations and the support of hard working and enthusiastic fundraisers across the country to continue our life saving work. We raise funds to continue our life-saving work and inspire others to do the same, so everyone affected by bowel cancer can live their best life.
Professor Molloy is the inaugural Lawrence Penn Chair of Bowel Cancer Research at The University of Sydney.
Professor Molloy is a PhD scientist with 20+ years experience applying molecular technologies including proteomics and genomics to study cancer. His research examines the molecular aspects of bowel cancer development and how biomarkers can be used to personalise patient treatments to achieve best outcomes.
Professor Molloy has authored more than 200 research publications and received research grants from the National Health and Medical Research Council, Australian Research Council, and Cancer Institute NSW, amongst others.
He has supervised 14 PhD students and mentored many early career research fellows.
Professor Molloy is passionate about bridging science and clinical medicine to improve lives and outcomes for people at risk of bowel cancer and for those patients with the disease.
For assistance with media enquiries, including arranging interviews with any of our team (e.g. specialists, nurses, nutritionists, CEO) patients or loved ones from around Australia.